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Abstract.  Neurofibromas are benign tumors from pa- 
tients with von Recklinghausen Neurofibromatosis 
(NF1)  that are comprised primarily of Schwann cells. 
These Schwann cells are found both in association 
with axons and in the extracellular matrix that is 
prevalent in neurofibromas, and in which fibroblasts 
are also abundant. An unresolved question has been 
whether cells in neurofibromas are normal cells or are 
intrinsically abnormal.  We have tested the hypothesis 
that cells in neurofihromas are abnormal and have 
shown that neurofibroma Schwann cells, unlike normal 
Schwann cells, promote angiogenesis in the chick 
chorioallantoic membrane model system, and invade 
basement membranes in this system. In contrast, 
neurofibroma fibroblasts neither promote angiogenic 
reactions nor invade basement membranes. When in- 
jected into nude mice, neurofibroma Schwann cells do 
not form progressive tumors. These results suggest 
that NF1  Schwann cells differ from normal Schwann 
cells, that they are preneoplastic, and that genetic 
and/or epigenetic changes in Schwann cells may be 
required for development of peripheral nerve tumors 
in NF1. 
single gene defect causes 1 in 4,000 humans to develop 
a  syndrome known as  type  1  neurofibromatosis, 
which is inherited in an autosomal dominant manner 
(6, 8). von Recklinghausen type 1 neurofibromatosis (NF1) 1 
is characterized by enormous variability in presentation; the 
number of different symptoms that can be expressed by pa- 
tients with NF1 has made it difficult  to assess which cell type, 
or types, are defective as a result of the NF1 mutation (33). 
A common abnormality expressed in NF1 is the formation 
of peripheral nerve tumors called neurofibromas, which are 
composed of 60-85%  Schwann cells  and  10-20%  fibro- 
blasts, with lesser numbers of pericytes, perineurial cells, 
mast cells, endothelial cells, and smooth muscle cells, all of 
which are enveloped by extensive extracellular matrix (24). 
Several observations suggest that Schwann cells may be the 
primary target of factors stimulating neurofibroma forma- 
tion (29).  Schwann cells in normal nerves are found only in 
association with axons (50), whereas in neurofibromas they 
are present both associated with bundles of axons and free 
in the extracellular matrix (17, 27).  In addition, Schwann 
cells are the major cell type amplified in neurofibromas (25, 
42, 48), and malignant tumors (Schwannomas, neurofibro- 
sarcomas) arising from neurofibromas are Schwann cell tu- 
mors (10, 15, 47).  Strikingly, a rare form of neurofibroma 
termed "onion-bulb" neurofibromas are composed solely of 
concentric rings of Schwann cells surrounding axons (23). 
However, it is not known whether neurofibroma Schwann 
cells  are  normal cells  that behave aberrantly in  the NF1 
1. Abbreviations  used in this paper:  bFGF, basic fibroblast growth factor; 
CAM,  chorioallantoic  membrane;  NF1,  Von  Recklinghausen  type  1 
Neurofibromatosis. 
milieu or whether they are intrinsically abnormal. Some evi- 
dence suggests that neurofibroma Schwann cells might retain 
normal  growth  properties.  We  have  recently shown that 
neurofibromas contain growth factor(s) that stimulate the 
proliferation of normal Schwann cells, and might stimulate 
Schwann cell division within tumors (29). In addition, when 
neurofibroma Schwann cells are placed into tissue culture, 
they do not proliferate. Instead, like normal Schwann cells, 
neurofibroma Schwann ceils  can  be  stimulated to  divide 
when exposed to specific Schwann cell mitogens (19, 30, 39, 
40). 
In this  study, we have determined the extent to which 
neumfibroma cells behave like normal or transformed cells 
by using several assays.  The growth of tumors is dependent 
upon stimulation of angiogenesis (11-13), since solid tumors 
do not make their own blood vessels but induce them from 
the host (22, 49).  We have previously shown that neurofi- 
bromas contain basic  fibroblast growth factor (bFGF),  a 
mitogen for mesenchymai ceils (29) which is also a potent 
angiogenesis-promoting factor. Therefore, we have compared 
the ability of neurofibroma cells and normal Schwann cells 
to stimulate blood vessel formation, which can occur during 
transition of cells from hyperplastic to neoplastic state (13). 
We have also tested whether NF1  cells are able to invade 
basement membranes,  since the ability to degrade matrix 
components is thought to be important in the development 
of the transformed phenotype (9, 37). 
Angiogenic and invasive assays used the chorioallantoic 
membrane (CAM) of developing chick embryos, which pro- 
vides a substrate for cells for long (up to 13 d) periods of 
time and enables observation of  both angiogenic and invasive 
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ful since the chick embryo is immune incompetent, so that 
the behavior of tumor cells can be studied in the absence of 
a host immune response. In this assay, normal cells remain 
on the top of the CAM whereas transformed cells invade the 
ectodermal and mesodermal layers of the membrane. 
To further analyze properties of NF1 cells, we examined 
their  capacity to  form tumors  in  nude  mice,  since  trans- 
formed cells can form tumors in these immunocompromised 
hosts (36). 
The  data  presented  in  this  report  indicates  that  NFI 
Schwann  cells  differ  from normal  Schwann  cells.  Unlike 
their normal counterparts, NF1 Schwann cells manifest sev- 
eral, but not all, characteristics of transformed cells. In con- 
trast, neurofibroma fibroblasts do not display any character- 
istics consistent with a transformed phenotype. 
Materials and Methods 
Human Tissue Specimens 
NF1 tumor samples were obtained incidental to therapeutic surgery from 
15 patients ranging in age from 9-74 yr, of  both sexes, meeting the diagnos- 
tic criteria for NF1 (6).  Two subcutaneous neurofibromas, four cutaneous 
neurofibromas, five plexiform neurofibromas, and four undesignated neuro- 
fibromas were studied. Specimens were collected into sterile tissue culture 
medium and used within 36 h for CAM assay or cell culture. Tv~ non-NF1 
human peripheral nerves (sural) were obtained. One nerve was obtained 
from a patient (age and sex data not available)  with brachial plexus palsy 
whose normal sural nerve was removed for transplantation with the shoul- 
der girdle. Another was obtained from a  14-yr-old  female with osteosar- 
coma whose leg was amputated due to tumor growth; the sural nerve was 
distant from the tumor, which was limited to the bone. This patient mani- 
fested no clinical peripheral neuropathy. Sural nerves were collected into 
tissue culture medium within 30 min of biopsy and stored for no more than 
20 h at 4°C. For addition to the CAM, human sural nerves were stripped 
of epineurium, and minced into  1-mm  3 pieces. No attempt was made to 
purify cells from these control nerves since the sural nerves were not large 
enough to generate sufficient numbers of cells for CAM assays. 
Preparation of Neurofibroma Tissue Fragments and 
Neurofibroma Cells 
Cell-rich nodules were dissected from neurofibroma matrix and minced into 
1-mm pieces in Leibowitz's L15 medium. In some experiments cells were 
dissociated from these nodules. Tumor nodules (1-5  g) were thoroughly 
minced and washed in L-15 medium, passed through cotton gauze to remove 
large pieces, and suspended in L-15 medium containing 1.25 U/ml Dispase 
(crude; Boehringer Mannheim GmBH,  Mannheim, Federal Republic of 
Germany), 0.05 % (wt/vol) CLS 1 collagenase (Worthington Biochemicals, 
Freehold,  NJ),  0.1%  (wt/vol) hyaluronidase (Sigma Chemical  Co.,  St. 
Louis, MO) (10 ml/g tumor) as described by Pleasure et al. (26). Digestion 
was carried out on a rotating shaker (60 revolutions per minute) at 37°C 
for 16-24 h. Dissociated cells were washed twice in DME containing 10% 
FCS followed by two washes in serum-free DME, then suspended in DME 
such that 10/zl contained 5  x  105 cells for placement onto the CAM. 
To enrich neurofibroma cells for Schwann cells, 8.3  ×  106 dissociated 
cells were allowed to attach to 100-mm  2 tissue culture plastic dishes for 5 
min in DME  +  10% FCS; nonadherent cells were subjected to a second 
round of differential adhesion.  Alternatively, after differential adhesion, 
neurofibroma cells were plated onto 100-mm dishes coated with air-dried 
rat  tail  collagen in  DME  containing  10%  FCS  for  14  d;  medium was 
replenished every 3 d, then cells were subjected to two additional rounds 
of differential adhesion. The remaining nonadherent cells (using either pro- 
tocol) were 85-90%  $100 +, as analyzed by immunostaining after plating 
onto glass Lab-Tek  slides, indicating that the cultures were enriched in 
Schwann cells. 
To  enrich  for  neurofibroma  fibroblasts,  the  attached  cells  from  the 
differential adhesion step 5  ×  105 were plated into a T-75 flask, expanded 
to confluence in DME with 10% FCS, and split 1:3 as necessary. Cells were 
removed from the substrate by trypsinization, washed as described above, 
and added to the CAM 7 or 14 d after initial plating. These cultures con- 
tained cells that were 95%  fibronectin  +,  5%  factor VIII  +,  and smooth 
muscle actin-, indicating that 95%  of the cells were fibroblasts (and/or 
perineurial cells), and 5%  were endothelial cells. 
Additional Cell Culture 
Normal rat Schwann cells were purified from neonatal rat sciatic nerve as 
described previously (5). Normal peripheral nerve fibroblasts were purified 
from the same sciatic nerve cultures by plating cells at low density, expand- 
ing them to confluence, and replating after trypsinization using a 1:10 split. 
Two to three subcultures were carried out before the addition of cells to 
CAM. RN22 Schwannoma cells and neurofibrosarcoma cells were grown 
in DME with 1(3% FCS. Neurofibrosarcoma cell lines were obtained from 
R. Martuza (Massachusetts General Hospital, Boston, MA), and T. Glover 
(University of Michigan, Ann Arbor, MI). These cells were maintained in 
DME with 10%  horse serum and 10% FCS. 
Chicken ChorioaUantoic Membrane Assay 
for Angiogenesis 
The surface of 6-d postfertilization chicken eggs (White Leghorn; Spafas, 
Inc., Roanoke, IL) were sterilized with betadine and the CAM exposed by 
cutting a window (1 cm  2) on one side of the egg using the false air sac tech- 
nique (1). After 24-48 h,  1-mm  3 tissue fragments (one to three pieces) or 
cells (5  ×  l(Y  s, washed twice in DME) were placed on the exposed CAM, 
the windows sealed with Scotch tape, and the eggs incubated in a humid 
incubator at 35°C. Eggs were removed from the incubator at intervals for 
observation using a stereoscopic dissection microscope and assessed for an- 
giogenesis; more than five loops of host blood vessels, delineating the added 
tissue or cells, was scored as a positive angiogenic response. In some experi- 
ments, 0.1-1 ng bFGF (Collaborative Research, Bedford, MA) was ad- 
sorbed to 1 x  1 × 2-mm pieces of Gelfoam (Upjohn Co., Kalamazoo, MD 
and placed onto the CAM (44). 
Invasiveness Assays 
The portion of the CAM containing cells or fragments was excised, fixed 
in 10%  neutral buffered formalin, paraffin embedded, and 6-pm sections 
cut through the entire tissue block. For histological analysis, the sections 
were stained with hematoxylin and eosin and each section analyzed for the 
presence of tumors within the CAM. 
Polystyrene Bead Experiments 
ll.9-/~m polystyrene beads (Ernest E  Fullam,  Inc.,  Latham,  NY)  were 
washed in DME  +  10%  FCS twice by centrffugation, washed twice in 
DME, counted in a hemocytometer, and 5  x  l0  s added to the CAM in 10 
#1  DME.  Alternatively,  beads  were  mixed  with  equal  numbers  of 
neurofibroma Schwann cells or neurofibroma derived fibroblasts, then har- 
vested by centrifugation and added to the CAM. 
Nude Mice Assays 
Neurofibromas were obtained immediately after biopsy, minced in L-15 
medium, the medium aspirated, and the resulting fragments suspended in 
1 rni L-15 and injected into the subcutaneous tissue on both sides of  the flank 
(0.5  ml/side) of 10-wk-old  BALB/c-derived nude mice (Harlan Sprngue 
Dawley, Indianapolis, IN) using a trocar needle and syringe (13-gange).  The 
inoculated mice were observed at weekly intervals and tumor growth was 
measured in three dimensions using a millimeter ruler. Animals were ob- 
served for up to 15 wk. Six animals showing palpable tumor were killed 
after 2-3 mo, the tumors removed and fixed in 10% neutral buffered forma- 
lin, cryoprotected, and frozen. 10-/zm cryostat sections were stained with 
hematoxylin and eosin or immunostained. 
Immunohistochemistry 
To identify cells in paraffin sections, sections were dried onto glass slides, 
deparaffinized, and then rehydrated. Sections were washed in phosphate- 
buffered saline and endogenous peroxidase activity blocked by a 15-min in- 
cubation in 0.3%  hydrogen peroxide in methanol, washed in PBS,  and 
treated with 0.1% trypsin (1:250;  Gibco Laboratories, Grand Island, NY) 
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Figure 2. Angiogenic response of the chicken CAM to neurofibro- 
ma fragments or ceils is time dependent: Neurofibroma fragments 
(A) or cells dissociated  from neurofibromas (B) were placed on 6-7- 
d-old embryonic CAM and scored for angiogenesis at various inter- 
vals thereafter. Each symbol represents the percent of angiogenic 
reactions in four to six eggs incubated with cells or fragments from 
a different neurofibroma. 
Moore, Washington  University, St.  Louis, MO) for 1 h before addition to 
sections; in other experiments the negative control was nonimmune rabbit 
serum; in either case, no staining was observed. SI00 and nerve growth fac- 
tor antibodies have been previously shown to label neurofibroma Sehwann 
cells (41, 42). In some experiments sections were counterstained with he- 
matoxylin and eosin. Cryostat sections were stained using the same proce- 
dure, except that deparaflinization and trypsinization were omitted and sec- 
tions were blocked in 10%  normal goat serum. Cultured cells were fixed 
in  -20"C  100%  methanol for 10 rain, washed, and stained as described 
beginning with the blocking step. 
Results 
Induction of  Angiogenesis 
Normal  rat  Schwann  cells,  normal  rat  peripheral  nerve 
fibroblasts, and  fragments  of non-NF1  adult human  nerve 
Figure 1.  Angiogenic response of the chicken CAM to  neurofi- 
broma fragments. In a, fragments of non-NF1 human sural nerve 
were placed onto 7-d-old embryonic CAM. Blood vessels show a 
random arrangement with respect to the tissue fragments (arrow- 
heads). In b, neurofibroma fragments were placed onto the CAM 
and stimulated a vigorous angiogenic response; many loops of host 
blood vessels (white arrows) delineate one fragment (arrowhead). 
Both specimens were photographed 10 d after addition of human 
tissue to the CAM. 
and 0.1%  calcium chloride,  pH  7.6 for  15  rain  at 37°C.  Sections were 
blocked in 2% normal goat serum diluted in PBS containing 1% BSA. The 
sections were then incubated with antibody overnight at 4"C or at room tem- 
perature for 30 rain.  Biotinylated second antibody (Vector Laboratories, 
Inc., Budingame, CA) was visualized as directed by the manufacturer, using 
the ELITE kit.  Staining for S100 (1:300) and Factor VIII (1:400) (Dako 
Corp.,  Santa Barbara,  CA),  fibronoctin (1:100)  (Biogenex Laboratories, 
Dublin, CA), and nerve growth factor receptor (1:2)  (31) was carded out 
under identical conditions, using appropriate second antibodies. In some 
experiments anti-S100 was incubated with S100 protein (a gift of Dr.  B. 
Table L Neurofibroma Fragments and Cells from 
Neurofibromas Invade the Chick CAM 
Number of  Number of 
Sample  Invasion  samples  experiments 
Non-NF1  human nerve fragments  0  12  2 
Normal rat  Schwarm cells  0  16  3 
Normal rat fibroblasts  0  11  2 
Neurofibroma fragments  46  41  7 
Neurofibroma cells  36  22  8 
Rat Schwarmoma, RN22  100  11  2 
Human neurofibrosarcoma  100  6  2 
Normal human sural nerve fragments (1  nun3),  neurofibmma fragments (1 
ram3),  or dissociated cells (5  x  10  s) were placed onto the chick CAM for 
7-13 d. The CAM was then excised and fixed, and embedded in paraffin. Inva- 
siveness was scored by microscopic  inspection of hematoxylin and eosin stained 
paraffin sections. A sample was counted positive for invasion if cells had invaded 
only the ectoderm or both the ectoderm and mesoderm. Invasion of the ecto- 
derm without mesodermal invasion occurred in 2 out of 63 samples of neuro- 
fibromas and never in other samples. Results obtained for invasion of neum- 
fibroma fragments from different tumors are: % invasion (number of samples): 
60 (5), 80 (5), 40 (5), 50 (6),  11 (9), 38 (8), 50 (6). The results for neurofibro- 
ma cells are 50 (2),  33 (3),  25 (4), 0  (1),  33 (6),  50 (6). 
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CAM show the invasiveness of neurofibro- 
ma fragments and cells. Normal non-NFl 
human sural nerve fragments, neurofibro- 
ma fragments, or ceils dissociated from neu- 
rofibromas were placed onto the CAM for 
10 d.  The CAM was  fixed,  embedded in 
paraffin, and 10-~m sections stained with 
hematoxylin and eosin. Normal nerve frag- 
ments (a) failed to invade CAM, leaving the 
CAM layers intact; NF1 fragments (c and d) 
or cells (b) caused the invasion  of many cells 
into the mesoderm with enormous enlarge- 
ment of the CAM. In b, small arrows show 
a  large blood vessel,  and the large arrow 
shows a region of normal CAM at the edge 
of the enlarged CAM tumor. In d, the white 
arrow points toward a large area of necrosis, 
while the black arrow points towards a tu- 
mor nodule containing  tightly packed cells. 
Bar, 500/zm. 
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trast, NF tumor fragments from eight patients stimulated an- 
giogenesis, which was easily detected by visual inspection; 
loops of blood vessels delineated the fragments (Fig. 1). An- 
giogenesis was detectable in 25 % of the samples after 2 d. 
By 10 d, 80%of eggs to which neurofibroma fragments had 
been added showed an angiogenic response (Fig.  2 A).  In 
contrast, the angiogenic factor bFGF (0.1 ng) placed onto the 
CAM stimulated angiogenesis within 48 h in six out of six 
samples.  The more gradual  increase  in  angiogenesis  ob- 
served after addition of tumor fragments to the CAM sug- 
gested  that  angiogenic  factor(s)  might  be  synthesized  in 
neurofibromas, and not  simply synthesized elsewhere and 
accumulated in the tumor matrix. 
To distinguish  these alternatives,  cells were dissociated 
from neurofibromas,  washed,  and  placed onto the CAM. 
Cells from six tumors were analyzed in this manner; as in 
the  case  of fragments,  neovascularization  increased  with 
time. 95 % of the samples tested showed blood vessel forma- 
tion by 10 d on the CAM, suggesting that neurofibroma cells 
themselves produce angiogenic factor(s) (Fig. 2 B). 
To determine whether either or both of the two major cell 
types in  neurofibromas, Schwann cells,  or fibroblasts was 
responsible for neovascularization we prepared cultures en- 
riched for each of  these cell types and applied them individu- 
ally to the CAM. Cultures containing >95 % fibroblasts did 
not stimulate angiogenesis  (0 out of 12  samples  stimulat- 
ed  angiogenesis),  while  Schwann  cell-enriched  cultures 
(85-90%  S100  ÷ ceils) were highly angiogenic (6 out of 6 
samples  showed  angiogenesis),  suggesting  that  Schwann 
cells  are  responsible  for  the  angiogenic  response.  This 
phenotype was retained after Schwann cells were removed 
from the tumor environment, since Schwann cell-enriched 
cultures, maintained in vitro for 2 wk before addition to the 
CAM, retained their ability to stimulate angiogenesis in six 
out of six samples. 
lnvasiveness of Neurofibroma Schwann Cells 
Normal rat Schwann cells, normal rat fibroblasts, fragments 
of non-NF1 human nerve, and neurofibroma fibroblasts did 
not invade the  CAM  (Table I).  In  contrast,  neurofibroma 
fragments and dissociated cells from nine different tumors 
applied to the CAM were invasive (Table I and Fig. 3). Inva- 
sive tumor cells infiltrated the CAM ectoderm and expanded 
into loosely arranged stroma of  the mesoderm. Large tumors 
frequently induced areas of necrosis within the CAM meso- 
derm. Of neurofibroma fragments added to the CAM, 46 % 
(19 out of 41) were invasive (Table I). Similarly, 36.4%  (8 
out of 22) of dissociated cell samples from neurofibromas 
were invasive. Similar percentages were observed at 5, 7, 10, 
or  13  d  of incubation  on  the  CAM;  data  was  therefore 
pooled. 
To  identify  the  cell  type(s)  with  invasive  properties, 
paraffin sections were immunostained with antibodies that 
recognize SIO0 or nerve growth factor receptor (to mark 
Schwann cells), factor VIII (to mark endothelial cells), or 
fibronectin  (to  mark  fibroblasts).  Sections  of  CAM  in- 
cubated with fragments of non-NFl  human nerve did not 
show any staining for SIO0 or nerve growth factor receptor 
within the ectoderm or mesoderm; stained cells were present 
only on top of the ectodermal layer (not shown). In contrast, 
when neurofibroma ceils were added to the CAM, sections 
showed cells within the CAM mesoderm which were stained 
by the Schwann cell markers (Fig. 4, b and c). Lesser num- 
bers of cells within the CAM  mesoderm were labeled by 
using anti-fibronectin (Fig.  4  a).  Factor VIIi-specific an- 
tisera stained a few cells in some sections, and none in other 
sections (not shown). At the concentrations used, anti-fibro- 
nectin and anti-factor VIII antisera did not stain chicken epi- 
topes within the CAM mesoderm. However, factor VIII anti- 
bodies did stain cells associated with chicken blood vessels. 
As further confirmation that the Schwann cell is the major 
Figure 4. Immunohistochemical analysis of neurofibroma cells within the CAM. Neurofibroma fragments were placed onto the CAM as 
in Fig. 3, and serial 6-~m paraffin sections stained with anti-fibmnectin (a) to identify fibroblasts or anti-S100 to label Schwann ceils (b). 
Sections were counterstained with hematoxylin before photography. In c, an enlargement of b showing the typical spindle-shaped morphol- 
ogy of cells stained by the S100 antibody, indicative of Schwann ceils. Bars: (a and b) 100 #m; (c) 200/zm. 
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into the CAM 
We were puzzled by the observation that when mixed popu- 
lations of neurofibroma cells were added to the CAM,  not 
only Schwann ceils but also fibroblasts and endothelial cells 
were detected in the CAM mesoderm. One possible explana- 
tion for this finding is that disruption of the ectodermal layer 
by neurofibroma Schwann cells allows nonspecific invasion 
of all tumor cells into the CAM mesoderm. To test this possi- 
bility, polystyrene beads were applied to the CAM alone or 
together with neurofibroma cells,  the samples were fixed, 
embedded  in  paraffin,  and  sections  analyzed.  In  samples 
containing beads alone or beads together with neurofibroma 
fibroblasts, the beads remained on top of the CAM ectoderm 
(Fig. 6, a and b). However, in the presence of neurofibroma 
Schwarm ceils, beads were observed not only on the surface 
of the CAM but also within the mesodermal layer (Fig. 6 c). 
These experiments suggest that while neurofibroma Schwann 
cells are likely to be sufficient for invasion of the CAM, other 
ceils (or beads) can use breeches in the ectoderm formed by 
Schwann cells to enter the CAM mesoderm. 
Figure 5. Neurofibroma Schwann cells invade the CAM. Schwann 
cells were enriched from neurofibroma cell cultures by differential 
adhesion.  After 14 d  in vitro,  5  ×  105 cells  were added to the 
CAM.  14 d later the CAM was excised, fixed, embedded in par- 
aflin, and 6-#m sections were immunostained using a monoclonal 
antibody directed against human nerve growth factor receptor. No 
counterstain was used. A large number of  cells within a tumor nod- 
ule are NGFR  + human Schwann cells.  Bar, 400 ttm. 
invasive cell in neurofibromas, enriched cultures of Schwann 
cells or fibroblasts were prepared and separately added to the 
CAM. After 13 d, the CAMS were fixed. Histological sec- 
tions from experiments in which Schwann cells were added 
to the CAM (six out of six) showed mesodermal tumors. In 
another experiment,  Schwann cell-enriched cultures  from 
different patients were maintained in vitro for 14 d before ad- 
dition to the CAM. All of the samples (six out of six) showed 
invasion of the CAM. In contrast, neurofibroma fibroblasts 
from the same tumors failed to invade the CAM, further sup- 
porting the contention that Schwann cells in neurofibromas 
are responsible for the invasive behavior of neurofibromas. 
These results were confirmed by immunocytochemistry. 
When paraffin sections of CAM to which Schwann cell- 
enriched cultures had been added were immunostained, large 
numbers of cells within the CAM were stained by S100 or 
nerve growth factor receptor antibodies (Fig. 5) whereas lit- 
tle, if any, specific cellular staining was observed using anti- 
fibronectin  (not  shown).  Staining  with  anti-nerve  growth 
factor receptor antibody is especially significant because this 
monoclonal  antibody  recognizes  human,  but  not  chicken 
Schwann cells, confirming that S~hwann cells within the CAM 
are or neurofibroma origin. Human neurofibrosarcoma and 
rat Schwannoma cells were also invasive in this system (Ta- 
ble I), corroborating the idea that transformed Schwann cells 
are invasive. 
Dissociation of  Angiogenic and Invasive  Responses 
The data in Fig.  1 and Table I indicate that 85 % of samples 
containing  tumor  fragments  or  dissociated  neurofibroma 
cells stimulated angiogenesis on the chicken CAM  within 
10 d. Invasion, however, was observed in only 55% of sam- 
ples within the same time frame. This result indicates that 
angiogenic signals from neurofibroma cells were not suffi- 
cient to promote invasiveness. In addition,  2% of samples 
analyzed were invasive in the absence of angiogenesis, sug- 
gesting  that  invasiveness  and  angiogenesis  are  separable 
events in this system. 
Growth of  Neurofibromas in Nude Mice 
Neurofibromas  did  not  produce  progressively  growing 
tumors after injection into nude mice. Fig. 7 shows measure- 
ments of tumor volume from 20  samples (from eight pa- 
tients) injected into nude mice. While none of these samples 
showed  progressive  growth,  many  transiently  manifested 
small increases in volume over several weeks. By 10-13-wk 
post  injection  all  tumors  had  become  stationary  or  had 
regressed completely. 
Cryostat sections of seven tumors were analyzed 8-12 wk 
after  injection  into  nude  mice by hematoxylin and  eosin 
staining. In no case were areas of necrosis observed. Rather, 
a loose meshwork of extracellular matrix was observed, in 
which spindle shaped cells were embedded; nerve bundles 
were also observed (Fig. 8 a). A perineurial sheath around 
nerve bundles was not observed. To corroborate the identifi- 
cation of Schwann cells in these samples, sections were im- 
munostained with antibodies to S100.  S100  + cells were ob- 
served both within the matrix and in the apparent nerve bun- 
dles (Fig. 8 b). Since neuronal cell bodies are not present in 
most neurofibromas,  the axons in  these nerve bundles are 
probably  of mouse  origin,  suggesting  that  neurofibroma 
Schwann cells form interactions with mouse axons and sur- 
vive in nude mice for at least several months. 
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Figure 7. Neurofibroma ceils do not form tumors in nude mice. A 
total of  20 neurofibroma samples were injected subcutaneously into 
nude mice; tumor volume was measured weekly. Each line rep- 
resents measurements from a single sample. While many samples 
underwent transient increases in volume, all had completely re- 
gressed or stopped'growing by 13 wk after injection. 
Figure 6. Nonspecific invasion of the CAM by polystrene beads in 
the  presence  of neurofibroma Schwann cells.  Polystrene beads 
placed onto the CAM alone (a) or mixed with neurofibroma fibro- 
blasts (b) stayed on top of  CAM. In contrast, when beads were added 
to the CAM together with neurofibroma Schwann cells, beads en- 
tered  the  CAM  mesoderm  (c).  Hematoxylin and  eosin  stained 
paraffin sections were photographed using dark field illumination. 
Bar,  176 t~m. 
Discussion 
Our results show that neurofibroma Schwann cells produce 
angiogenic factor(s) and invade basement membranes. These 
properties are retained for at least 2 wk after separation of 
cells from their in vivo milieu. In contrast, neither fragments 
of normal human nerve nor fibroblasts purified from neuro- 
fibromas stimulate angiogenesis or invade basement mem- 
branes.  These results indicate that angiogenic and invasive 
properties'are restricted to Schwann cells within neurofibro- 
mas. Although unlikely, we cannot formally exclude the pos- 
sibility that fibroblasts contribute to the expression of these 
characteristics by neurofibroma-derived Schwann cells, since 
all Schwann cell cultures retained some contaminating fibro- 
blasts. 
This report is the first to demonstrate that Schwann cells 
have angiogenic potential.  Blood vessel formation can be 
stimulated by a number of polypeptides, including angioge- 
nin, transforming growth factors ot and ~, epidermal growth 
factor, and the fibroblast growth factors,  acidic and basic 
FGF; additional, less well characterized angiogenic factors 
have also been described (reviewed in reference 12). Which 
of these polypeptides contribute to stimulation of blood ves- 
sel formation by neurofibroma Schwann cells has not been 
addressed in this study. However, using biochemical and im- 
munological criteria we have previously shown that the an- 
giogenic factor bFGF is present in 60%  of neurofibromas 
analyzed (29),  suggesting  that bFGF  might contribute to 
neovascularization in most neurofibromas. Since all neuro- 
fibromas tested stimulated angiogenesis on the CAM,  it is 
possible that additional angiogenic factors are produced in 
some, or all, neurofibromas. Alternatively, lesser amounts of 
bFGF, below the limit of our detection, may be produced in 
some neurofibromas; this explanation is consistent with the 
fact some neurofibromas placed onto the CAM required longer 
times than others to produce an angiogenic response. 
The ability of neurofibroma cells to invade the CAM might 
be due to the production of a variety of enzymes, including 
collagenases and plasminogen activators, that have been im- 
plicated in the progression of normal to malignant cells (9, 
21, 45, 46). Consistent with this proposition, proteolytic ac- 
tivity in neurofibroma homogenates is 10-fold higher than in 
normal human peripheral nerve (20).  Many neurofibroma 
Schwann cells are separated from neurons in vivo. Since the 
amount of protease secreted by Schwann cells increases after 
denervation in a tissue culture model (3, 7), it was reasonable 
Sheela et al. Neurofibroma Sch~ann Cells  651 Figure 8.  Neurofibroma cells in nude mice.  Cryostat  sections of stationary  tumors were analyzed histologically after hematoxylin and 
eosin staining (a). A loose network of extracellular matrix in which spindle-shaped cells are embedded is shown, as is an example of a 
nerve bundle (arrow). Immunostaining for S100 (b) demonstrates that the spindle-shaped cells, both in the matrix and in the nerve bundle 
(arrow), are S100  ÷ Schwann cells. Bar,  100 #m. 
tO postulate that even normal Schwarm cells, after separation 
from axons, would invade the CAM. However, neither frag- 
ments of adult human nerve containing Schwann cells nor 
embryonic rat Schwann cells separated from axons for three 
weeks are invasive in this system. These data suggest that ax- 
otomy alone is not sufficient to cause Schwann cells to be- 
come invasive. 
After injection of neurofibromas into nude mice, tumor 
mass often underwent an initial increase. Transient increases 
in volume have been observed after injection of other benign 
tumors into nude mice (32, 34, 36) and may reflect vasculari- 
zation of tumor samples or the differentiation of tumor cells 
in nude mice. Nerve bundles were present in sections of all 
the  neurofibroma  stationary  tumors  analyzed,  suggesting 
that some Schwann cells injected into nude mice associate 
with  host  neurons.  These  data  show  that  neurofibroma 
Schwann  cells  are  competent to  undergo  the  first step  in 
Schwann  cell  differentiation characteristic  of these  sheath 
cells,  adhesion to axons (38).  Significantly,  neurofibromas 
failed to form progressive tumors in nude mice, even after 
5 mo. This observation is consistent with the clinical diagno- 
sis of neurofibromas as benign tumors. 
Our findings raise fundamental questions about the mech- 
anisms of neurofibroma formation. Neurofibroma Schwann 
cells fail to proliferate in vitro unless stimulated by the addi- 
tion of specific mitogens (20,  40),  and fail to grow in nude 
mice. However, the transition from a normal to a neoplastic 
cell is thought to occur by a series of mutations which occur 
during cell proliferation (4,  13,  16, 43).  Thus, hyperplasia 
serves as a contributing factor for the development of neopla- 
sia. For example, it has recently been shown that angiogenic 
activityin pancreatic islet cells appears after hyperplasia of 
cells hut before the onset of tumor formation (13).  In the ab- 
sence of an intrinsic ability to proliferate, how does Schwann 
cell hyperplasia occur in patients with NFI? We have previ- 
ously shown that Schwann cell mitogen is present in neuro- 
fibroma extracts (29). It is possible that mitogen production 
results in Schwarm cell hyperplasia and leads to the forma- 
tion of a  population of Schwann cells that develops trans- 
formed properties. Other solid tumors are known to convert 
to more invasive variants by the outgrowth of small popula- 
tions of cells that differ from the parental population (2,  18, 
28).  This model predicts that Schwarm cell abnormality in 
neurofibromas is a consequence of genetic and/or epigenetic 
transformation event(s) secondary to the NFI mutation, and 
therefore that Schwann cells not associated with neurofibro- 
mas in NF1 patients are untransformed. We favor this model 
since neurofibromas are present at some, and not all, loca- 
tions in NF1 patients.  However, it is also possible that the 
NF1 mutation itself causes Schwann cells to become invasive 
and to promote angiogenesis. If this is true, Schwann cells 
from peripheral nerves of patients with NF1 who do not have 
neurofibromas should display these pheotypes. Analysis of 
nonneurofibroma-related Schwann cells from NF1  patients 
in the transformation assays established in this paper will 
distinguish these hypotheses. 
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